Transcatheter closure has been widely accepted as a highly effective way to treat abnormal
blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of …

Atrial septal defect (ASD) is a common structural congenital heart disease. With the
development of interventional closure devices and transcatheter techniques, interventional …

Percutaneous closure of ventricular septal defect (VSD) can effectively occlude abnormal
blood flow between ventricles. However, commonly used Nitinol occlusion devices have non …

Atrial septal defect (ASD) and patent foramen ovale (PFO) are common clinical congenital
heart defects. As an effective method for the treatment of ASD and PFO, transcatheter …

Objective Atrial septal defect (ASD) is a general term used to describe an opening in the
atrial septum that divides the two atria; unless the hole is occluded, it can give rise to serious …

Implantation of occlusion devices is an effective approach for the treatment of congenital
heart diseases in the clinic. However, most commercial clinical occlusion devices are …

The next-generation closure device for interventional treatment of congenital heart disease
is regarded to be biodegradable, yet the corresponding biomaterial technique is still …

The purpose of this report was to develop novel biodegradable occlusion devices for closure
of atrial septal defects (ASD). To manufacture the biodegradable occluders …

This review examines the biomaterials used in occlusion devices for cardiac defects, and
how the choice of these materials is dictated by design. Specifically, the devices used in …

Degradable heart occluders are a promising replacement for currently clinically used non-
degradable ones without concerns about the complications caused by the persistent residue …